HRS-8829
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 29, 2026
Safety, Tolerability and Pharmacokinetic Study of HRS-8829
(clinicaltrials.gov)
- P1 | N=83 | Completed | Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Not yet recruiting ➔ Completed | Trial primary completion date: Oct 2025 ➔ Jan 2026
Trial completion • Trial primary completion date • Cardiovascular • Ischemic stroke
July 25, 2025
Safety, Tolerability and Pharmacokinetic Study of HRS-8829
(clinicaltrials.gov)
- P1 | N=70 | Not yet recruiting | Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
New P1 trial • Cardiovascular • Ischemic stroke
1 to 2
Of
2
Go to page
1